dc.contributor.author |
Dzhurabaeva, Muhabbat |
|
dc.contributor.author |
Anvarova, Ekaterina |
|
dc.contributor.author |
Sultanov, Sanjar |
|
dc.contributor.author |
Massavirov, Sherali |
|
dc.contributor.author |
Mukhamedov, Kozim |
|
dc.contributor.author |
Uteshev, Malik |
|
dc.contributor.author |
Babamatova, Khilola |
|
dc.contributor.author |
Sobirov, Akbar |
|
dc.contributor.author |
Rajapov, Javokhir |
|
dc.date.accessioned |
2021-12-27T09:01:48Z |
|
dc.date.available |
2021-12-27T09:01:48Z |
|
dc.date.issued |
2021-02-13 |
|
dc.identifier.issn |
0975-2366 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/1122 |
|
dc.description.abstract |
The World Health Organization (WHO) estimates that among 10.4 million tuberculosis patients worldwide,
1.2 million are people with HIV infection in 2015. To the 1.4 million deaths from tuberculosis worldwide that same year, WHO estimates that 400,000 deaths from tuberculosis-related HIV infection are added. According to WHO, HIV infection and tuberculosis are considered the most dangerous infectious diseases. Due to severe immunodeficiency, tuberculosis patients with HIV infection and AIDS are likely to develop severe systemic and disseminated forms of secondary fungal infection caused by Candida, Cryptococcus and other pathogens. Candidiasis - anthroponosis with contact mechanism of pathogen transmission, characterized by lesions of skin, mucous membranes and internal organs. |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
Epidemiology, Etiopathogenesis, Diagnosis and Treatment of Visceral Mycosis in Patients with Tuberculosis/HIV Infection Co-Infection |
en_US |
dc.relation.ispartofseries |
133; |
|
dc.subject |
tuberculosis, HIV-infection, HIV/TB co-infection, visceral mycosis, mycotic complications |
en_US |
dc.title |
Epidemiology, Etiopathogenesis, Diagnosis and Treatment of Visceral Mycosis in Patients with Tuberculosis/HIV Infection Co-Infection |
en_US |
dc.type |
Article |
en_US |